WNT signalling: mechanisms and therapeutic opportunities

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Dec 2017 English Publisher:WileyJournal:British Journal of Pharmacology, volume 174, pages 4,543-4,546 (issn: 0007-1188, eissn: 1476-5381,

Copyright policy )

Authors: Gunnar, Schulte; Vitezslav, Bryja;

doi: 10.1111/bph.14065

pmid: 29235106

pmc: PMC5727308

WNT signalling: mechanisms and therapeutic opportunities

- Summary
- Subjects
- Metrics

Abstract

This themed section of the British Journal of Pharmacology stems from the EMBO Conference: Wnt Meeting 2016 held from the 14th to 16th September 2016 in Brno, Czech Republic.Linked ArticlesThis article is part of a themed section on WNT Signalling: Mechanisms and Therapeutic Opportunities. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.24/issuetoc

Related Organizations

Karolinska Institute
Sweden
Masaryk University
Czech Republic

Keywords

Neoplasms, Cell Membrane, Humans, Antineoplastic Agents, Wnt Signaling Pathway

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	9
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average